Avingtrans Plc Adaptix appoints Willem Baralt as new Chairman

Avingtrans PLC (LON:AVG) has announced that further to the statement made on 14 December 2022, Adaptix, the Oxford based emerging MedTech Company, has appointed Willem Baralt as its new Chairman. Willem, previously of Quanta Dialysis Technologies, will succeed Steve McQuillan (CEO of Avingtrans), who was appointed to the Board of Adaptix in December 2022 in an interim capacity. Steve will continue as a Non-Executive Director of Adaptix.

In 2021, Avingtrans plc invested £4m in Adaptix, for an 11.9% stake in the business and in December 2022 announced a further investment of £2m by means of a Convertible Loan Note.

Share on:

You might also enjoy reading Avingtrans Plc Record Results, New Nuclear Wins and the Power of AI-Driven Demand (Video)

Written by: Giles

Latest Company News

Avingtrans subsidiary Adaptix gains FDA clearance for Ortho350

November 10, 2025

Avingtrans reported that its subsidiary Adaptix has received FDA 510(k) clearance for the Ortho350, a compact 3D orthopaedic imaging system designed for point of care use.

Avingtrans CEO on record revenue and strong order book momentum for FY25 (LON:AVG)

October 2, 2025

Avingtrans has delivered record revenue of £156.4 million for FY25, with Chief Executive Officer Steve McQuillan highlighting robust order book growth, major contract wins, and increasing demand across energy, defence, infrastructure and medical divisions.

Avingtrans appoints Stuart Gall as CEO of medical imaging division

September 29, 2025

Avingtrans Plc has announced the appointment of Stuart Gall as Divisional Chief Executive Officer of its medical imaging businesses, including Adaptix and Magnetica, effective on or before 10 March 2026.

Avingtrans Plc Record Results, New Nuclear Wins and the Power of AI-Driven Demand (Video)

September 25, 2025

Avingtrans CEO Steve McQuillan shares how AI, energy and infrastructure megatrends are driving record results — and why strategic deals could be back on the table in FY26.

Avingtrans reports record revenue and earnings growth in FY25

September 24, 2025

Avingtrans posted preliminary results for the year ended 31 May 2025, with revenue up 14.5% to a record £156.4m and adjusted EBITDA rising to £16.7m. Adjusted profit before tax increased 18% to £8.6m, while diluted EPS grew 28% to 23.7p.

Avingtrans secures $16m nuclear contracts with KHNP

September 2, 2025

Avingtrans’ US subsidiary, Hayward Tyler Inc., has won two contracts worth over $16m from Korea Hydro & Nuclear Power. The deals cover safety-related pumps and spare parts for nuclear reactors in South Korea, with manufacturing in Vermont and delivery scheduled by FY27.